$396 Million is the total value of Affinity Asset Advisors, LLC's 73 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 60.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SER TRput | $87,997,000 | +225.0% | 700,000 | +250.0% | 22.22% | +129.2% |
| SPY | New | SPDR S&P 500 ETF TRput | $42,914,000 | – | 100,000 | +100.0% | 10.84% | – |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $30,673,000 | -8.5% | 654,435 | +19.0% | 7.75% | -35.5% |
| VINC | Buy | VINCERX PHARMA INC | $16,251,000 | +49.2% | 1,005,000 | +19.9% | 4.10% | +5.3% |
| MORF | Buy | MORPHIC HLDG INC | $15,336,000 | +8.5% | 270,755 | +10.0% | 3.87% | -23.4% |
| NARI | Buy | INARI MED INC | $10,949,000 | +38.1% | 135,000 | +58.8% | 2.76% | -2.6% |
| KURA | Buy | KURA ONCOLOGY INC | $9,927,000 | +12.0% | 530,000 | +24.7% | 2.51% | -21.0% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $7,994,000 | +288.1% | 126,013 | +404.1% | 2.02% | +173.9% |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $7,669,000 | +49.7% | 259,966 | +30.0% | 1.94% | +5.6% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $7,500,000 | +111.6% | 750,000 | +200.0% | 1.89% | +49.3% |
| TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $7,056,000 | +17.7% | 7,000,000 | 0.0% | 1.78% | -16.9% | ||
| New | ARYA SCIENCES ACQUISITN CORP | $6,941,000 | – | 702,500 | +100.0% | 1.75% | – | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $6,300,000 | +30.5% | 350,000 | +27.3% | 1.59% | -8.0% |
| XLRN | Sell | ACCELERON PHARMA INC | $6,084,000 | -11.9% | 35,350 | -35.7% | 1.54% | -37.8% |
| ARYD | Sell | ARYA SCIENCES ACQU CORP IVcl a | $6,036,000 | -19.6% | 600,000 | -14.3% | 1.52% | -43.3% |
| NAUT | Buy | NAUTILUS BIOTECHNOLOGY INC | $5,987,000 | -34.1% | 975,000 | +8.3% | 1.51% | -53.5% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $5,724,000 | +117.6% | 35,910 | +79.6% | 1.45% | +53.5% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $5,165,000 | -31.8% | 77,500 | -45.6% | 1.30% | -51.9% |
| MRTX | New | MIRATI THERAPEUTICS INC | $4,865,000 | – | 27,500 | +100.0% | 1.23% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $4,850,000 | – | 200,000 | +100.0% | 1.22% | – |
| SAVA | New | CASSAVA SCIENCES INCput | $4,656,000 | – | 75,000 | +100.0% | 1.18% | – |
| CRIS | Sell | CURIS INC | $4,502,000 | -14.2% | 575,000 | -11.5% | 1.14% | -39.5% |
| CYTK | Buy | CYTOKINETICS INC | $4,468,000 | +222.6% | 125,000 | +78.6% | 1.13% | +127.4% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $4,295,000 | +145.9% | 60,000 | +200.0% | 1.08% | +73.6% |
| EDIT | New | EDITAS MEDICINE INCput | $4,108,000 | – | 100,000 | +100.0% | 1.04% | – |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $3,699,000 | +42.2% | 150,000 | +50.0% | 0.93% | +0.2% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $3,601,000 | +270.5% | 75,000 | +400.0% | 0.91% | +161.2% |
| New | TRILLIUM THERAPEUTICS INC | $3,512,000 | – | 200,000 | +100.0% | 0.89% | – | |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $3,393,000 | +128.2% | 203,183 | +203.5% | 0.86% | +61.1% |
| BLU | Buy | BELLUS HEALTH INC NEW | $3,267,000 | +250.2% | 532,030 | +77.3% | 0.82% | +147.0% |
| RFL | New | RAFAEL HLDGS INCput | $3,110,000 | – | 101,200 | +100.0% | 0.78% | – |
| New | PROCEPT BIOROBOTICS CORP | $2,996,000 | – | 78,534 | +100.0% | 0.76% | – | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $2,967,000 | -3.0% | 300,000 | 0.0% | 0.75% | -31.6% | |
| ENVI | New | ENVIRONMENTAL IMPACT ACQU CO | $2,967,000 | – | 300,000 | +100.0% | 0.75% | – |
| MSAC | MEDICUS SCIENCES ACQUISITION | $2,925,000 | +1.0% | 300,000 | 0.0% | 0.74% | -28.7% | |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $2,398,000 | -54.9% | 80,228 | -33.1% | 0.61% | -68.2% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $2,168,000 | +29.7% | 40,154 | -19.7% | 0.55% | -8.5% |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $2,108,000 | -6.3% | 400,000 | +5.3% | 0.53% | -33.9% |
| GOSSAMER BIO INCnote 5.000% 6/0 | $2,087,000 | +30.0% | 2,000,000 | 0.0% | 0.53% | -8.3% | ||
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $2,012,000 | +24.3% | 15,000 | +50.0% | 0.51% | -12.4% |
| HARP | Buy | HARPOON THERAPEUTICS INC | $1,975,000 | +184.6% | 250,000 | +400.0% | 0.50% | +101.2% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $1,911,000 | +173.0% | 75,000 | +275.0% | 0.48% | +92.4% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $1,846,000 | – | 10,000 | +100.0% | 0.47% | – |
| AFIB | Buy | ACUTUS MED INC | $1,768,000 | +30.2% | 200,000 | +150.0% | 0.45% | -8.2% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $1,736,000 | -23.4% | 197,759 | -1.1% | 0.44% | -46.0% |
| SEER | New | SEER INCcall | $1,727,000 | – | 50,000 | +100.0% | 0.44% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $1,643,000 | -29.8% | 15,000 | -40.0% | 0.42% | -50.5% |
| MREO | MEREO BIOPHARMA GROUP PLCads | $1,573,000 | -23.7% | 650,000 | 0.0% | 0.40% | -46.2% | |
| BFLY | Buy | BUTTERFLY NETWORK INC | $1,566,000 | +8.1% | 150,000 | +50.0% | 0.40% | -23.7% |
| LSAQ | LIFESCI ACQUISITION II CORP | $1,470,000 | -2.0% | 150,000 | 0.0% | 0.37% | -30.9% | |
| SDGR | SCHRODINGER INC | $1,367,000 | -27.7% | 25,000 | 0.0% | 0.34% | -49.0% | |
| PCVX | VAXCYTE INC | $1,269,000 | +12.7% | 50,000 | 0.0% | 0.32% | -20.6% | |
| ZYME | Buy | ZYMEWORKS INC | $1,127,000 | +8.3% | 38,814 | +29.4% | 0.28% | -23.6% |
| BLI | New | BERKELEY LTS INC | $1,076,000 | – | 55,000 | +100.0% | 0.27% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $1,064,000 | – | 111,400 | +100.0% | 0.27% | – |
| GLPG | GALAPAGOS NVspon adr | $1,052,000 | -24.2% | 20,000 | 0.0% | 0.27% | -46.5% | |
| New | RENOVACOR INC | $1,041,000 | – | 115,000 | +100.0% | 0.26% | – | |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,042,000 | – | 7,500 | +100.0% | 0.26% | – |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $949,000 | -66.4% | 74,341 | -62.8% | 0.24% | -76.3% |
| LUNG | Sell | PULMONX CORP | $900,000 | -66.0% | 25,000 | -58.3% | 0.23% | -76.1% |
| IMTXW | IMMATICS N.V*w exp 07/01/2020 | $800,000 | +22.3% | 190,000 | 0.0% | 0.20% | -13.7% | |
| ACHL | Buy | ACHILLES THERAPEUTICS PLCsponsored ads | $779,000 | -0.5% | 100,000 | +25.0% | 0.20% | -29.6% |
| IPHA | New | INNATE PHARMA S Asponsored ads | $771,000 | – | 125,000 | +100.0% | 0.20% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $764,000 | – | 50,000 | +100.0% | 0.19% | – |
| New | TANGO THERAPEUTICS INC | $647,000 | – | 50,000 | +100.0% | 0.16% | – | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $636,000 | +33.9% | 125,000 | +66.7% | 0.16% | -5.3% |
| SKINW | Sell | THE BEAUTY HEALTH COMPANY*w exp 05/04/2026 | $498,000 | +72.9% | 34,400 | -23.6% | 0.13% | +22.3% |
| KROS | New | KEROS THERAPEUTICS INC | $495,000 | – | 12,500 | +100.0% | 0.12% | – |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $445,000 | – | 250,000 | +100.0% | 0.11% | – |
| IMVT | IMMUNOVANT INCcall | $261,000 | -17.7% | 30,000 | 0.0% | 0.07% | -41.6% | |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $242,000 | – | 50,000 | +100.0% | 0.06% | – |
| New | RENOVACOR INC*w exp 99/99/999 | $60,000 | – | 75,000 | +100.0% | 0.02% | – | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/2026 | $24,000 | -29.4% | 33,333 | 0.0% | 0.01% | -50.0% | |
| CVRX | Exit | CVRX INC | $0 | – | -7,500 | -100.0% | -0.08% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -0.23% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.23% | – |
| CHAQU | Exit | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $0 | – | -75,000 | -100.0% | -0.29% | – |
| QSI | Exit | QUANTUM SI INC | $0 | – | -75,000 | -100.0% | -0.33% | – |
| CEREW | Exit | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/2020 | $0 | – | -72,466 | -100.0% | -0.37% | – |
| BCTG | Exit | BCTG ACQUISITION CORP | $0 | – | -100,000 | -100.0% | -0.41% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -85,000 | -100.0% | -0.41% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -45,000 | -100.0% | -0.42% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.43% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.60% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -70,000 | -100.0% | -0.72% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -80,000 | -100.0% | -0.77% | – |
| MRNA | Exit | MODERNA INCcall | $0 | – | -12,500 | -100.0% | -1.05% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INCcall | $0 | – | -75,000 | -100.0% | -1.07% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -25,000 | -100.0% | -1.52% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -140,100 | -100.0% | -2.25% | – |
| CVAC | Exit | CUREVAC N Vput | $0 | – | -150,000 | -100.0% | -3.95% | – |
| ARKG | Exit | ARK ETF TRput | $0 | – | -225,000 | -100.0% | -7.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-13 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.